Bausch + Lomb Corporation (BLCO) Stock Forecast
Data as of Jun 16, 2026Healthcare · Current price $15.10 (+0.63%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Jan 9, 2026 | David Roman | Goldman Sachs | $19.00 | +25.9% |
| Jan 5, 2026 | Vijay Kumar | Evercore ISI | $18.00 | +19.2% |
| Nov 14, 2025 | Douglas Miehm | RBC Capital | $19.00 | +25.9% |
| Nov 14, 2025 | Zachary Weiner | Jefferies | $20.00 | +32.5% |
| Dec 2, 2024 | Patrick Wood | Morgan Stanley | $19.00 | +25.9% |
| Oct 31, 2024 | Yi Chen | H.C. Wainwright | $23.00 | +52.4% |
| Oct 22, 2024 | Doug Miehm | RBC Capital | $23.00 | +52.4% |
| Oct 15, 2024 | Larry Biegelsen | Wells Fargo | $23.00 | +52.4% |
| Oct 15, 2024 | Vijay Kumar | Evercore ISI | $25.00 | +65.6% |
| Sep 23, 2024 | Tom Stephan | Stifel Nicolaus | $19.00 | +25.9% |
| Sep 19, 2024 | Zachary Weiner | Jefferies | $25.00 | +65.6% |
| Jul 22, 2024 | Doug Miehm | RBC Capital | $20.00 | +32.5% |
| May 6, 2024 | Patrick Wood | Morgan Stanley | $18.00 | +19.2% |
| May 8, 2023 | Yi Chen | H.C. Wainwright | $19.00 | +25.9% |
| Jul 28, 2022 | Vijay Kumar | Evercore ISI | $21.00 | +39.1% |
Top Analysts Covering BLCO
BLCO vs Sector & Market
| Metric | BLCO | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.67 | 2.24 | 2.41 |
| Analyst Count | 6 | 8 | 19 |
| Target Upside | +23.0% | +11475.0% | +17.1% |
| P/E Ratio | -15.45 | 4.04 | 31.98 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $1.36B | $1.37B | $1.38B | 8 |
| 2026-09-30 | $1.35B | $1.36B | $1.37B | 4 |
| 2026-12-31 | $1.47B | $1.49B | $1.50B | 7 |
| 2027-03-31 | $1.27B | $1.28B | $1.29B | 4 |
| 2027-06-30 | $1.45B | $1.46B | $1.48B | 6 |
| 2027-09-30 | $1.43B | $1.45B | $1.46B | 4 |
| 2027-12-31 | $1.56B | $1.58B | $1.59B | 7 |
| 2028-12-31 | $6.06B | $6.06B | $6.06B | 8 |
| 2029-12-31 | $5.88B | $5.93B | $5.97B | 7 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $0.10 | $0.15 | $0.19 | 8 |
| 2026-09-30 | $0.22 | $0.23 | $0.23 | 3 |
| 2026-12-31 | $0.33 | $0.34 | $0.34 | 6 |
| 2027-03-31 | $0.14 | $0.14 | $0.14 | 3 |
| 2027-06-30 | $0.30 | $0.30 | $0.31 | 5 |
| 2027-09-30 | $0.30 | $0.30 | $0.30 | 3 |
| 2027-12-31 | $0.41 | $0.42 | $0.42 | 6 |
| 2028-12-31 | $1.07 | $1.39 | $1.63 | 3 |
| 2029-12-31 | $1.76 | $1.78 | $1.79 | 1 |
Frequently Asked Questions
What is the analyst consensus for BLCO?
The consensus among 6 analysts covering Bausch + Lomb Corporation (BLCO) is Hold with an average price target of $18.90.
What is the highest price target for BLCO?
The highest price target for BLCO is $25.00, set by Vijay Kumar at Evercore ISI on 2024-10-15.
What is the lowest price target for BLCO?
The lowest price target for BLCO is $18.00, set by Patrick Wood at Morgan Stanley on 2024-05-06.
How many analysts cover BLCO?
6 analysts have issued ratings for Bausch + Lomb Corporation in the past 12 months.
Is BLCO a buy or sell right now?
Based on 6 analyst ratings, BLCO has a consensus rating of Hold (2.67/5) with a +23.0% upside to the consensus target of $18.90.
What are the earnings estimates for BLCO?
Analysts estimate BLCO will report EPS of $0.15 for the period ending 2026-06-30, with revenue estimated at $1.37B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.